Trial NCT05435053

View at ClinicalTrials.gov 
Org. Study IDs: 26092020
Secondary IDs: 2020-004623-17

Last trial update was posted on 2023-09-15

MeSH Interventions

Nivolumab

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Pancreas Cancer

Stopping Reasons

The study was terminated on the basis on an evaluation of the safety and efficacy of the 9 included patients of which 2 of the patients were excluded before receiving any study treatments, thus 7 patients were treated in the study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID